YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.
CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.
WYFF News 4 on MSN
Greer, South Carolina, family hosts fundraiser for gene therapy to treat children with rare disorder
A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...
8don MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback